Long-Term Liabilities: The sum of all non-current liabilities.
Actuate Therapeutics, Inc. (ACTU) had Long-Term Liabilities of $0.41M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.63M |
|
-- |
|
-- |
|
$5.71M |
|
$-5.71M |
|
$0.08M |
|
$-5.63M |
|
$-5.63M |
|
$-5.63M |
|
$-5.63M |
|
$-5.63M |
|
$-5.63M |
|
$-5.71M |
|
$-5.71M |
|
23.54M |
|
23.54M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$8.52M |
|
-- |
|
$0.39M |
|
$8.91M |
|
$4.72M |
|
-- |
|
|
Long-Term Liabilities |
$0.41M |
$5.13M |
|
$3.78M |
|
$3.78M |
|
$3.78M |
|
23.71M |
|
| Cash Flow Statement Financials | |
$-5.02M |
|
-- |
|
$-0.01M |
|
$13.16M |
|
$8.13M |
|
$-5.03M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-148.66% |
|
-148.66% |
|
-63.13% |
|
-148.66% |
|
$0.16 |
|
$-0.21 |
|
$-0.21 |
|